Welcome to Psychiatryai.com: Latest Evidence - RAISR4D

Estimated reading time for CME/CPD: 1 min

Psychotropic medications in mood disorders: to deprescribe or not?

AI Summary
  • Deprescribing psychotropic medications for mood disorders has gained increasing attention and clinical importance.
  • Guidelines provide expert consensus suggestions for clinical implementation of deprescribing strategies.
  • Key recommendations require practical execution across varied clinical contexts and integration into routine practice.
Summarise with AI (MRCPsych/FRANZCP)

Br J Psychiatry. 2026 Sep 14:1-5. doi: 10.1192/bjp.2026.10779. Online ahead of print.

ABSTRACT

In recent years deprescribing mood disorder medications has attracted increasing attention, and guidance provides suggestions for clinical implementation of deprescribing strategies that have been derived through expert consensus. Summarising and highlighting key recommendations, we discuss their execution in various clinical contexts and discuss their integration into clinical practice.

PMID:42734074 | DOI:10.1192/bjp.2026.10779

Document this CPD

Share Evidence Blueprint

QR Code

Save to Google Notes

Search Google Scholar

Save as PDF

My Revision List

close chatgpt icon
ChatGPT

Enter your request.

← →
RAISR4D CME/CPD Evidence Nodes
Swipe to navigate RAISR4D CME/CPD evidence nodes.
CME/CPD